This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
TUESDAY, April 29, 2025 The push to remove artificial colors from U.S. foods is gaining speed, but making the change won't be easy or quick.Last week, U.S. health officials directed food companies to voluntarily phase out petroleum-based syn.
TUESDAY, April 29, 2025 Dads are supposed to be strong, steady and stoic, given how theyre portrayed in sitcoms and family entertainment.But in real life, fathers sometimes falter and brushing it off can have a devastating impact on their kids.
A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved a 100% overall response rate and a 50% complete remission rate, in addition to a favorable safety profile and high in vivo persistence of CAR30+ cells.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
TUESDAY, April 29, 2025 -- Nearly two-thirds of cardiac arrest cases could be prevented by managing lifestyle, environmental and personal health risks, a new study says.Researchers found that addressing 56 everyday risk factors for sudden cardiac.
Researchers have shown they can inexpensively nanomanufacture silk microneedles to precisely fortify crops, monitor plant health, and detect soil toxins.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Researchers have shown they can inexpensively nanomanufacture silk microneedles to precisely fortify crops, monitor plant health, and detect soil toxins.
TUESDAY, April 29, 2025 -- People with autism do not appear to be at greater risk of age-related brain decline, a new study says.Older people with autistic traits have no differences when it comes to spatial working memory, which helps folks.
The global energy system may be faced with an inescapable trade-off between urgently addressing climate change versus avoiding an energy shortfall, according to a new energy scenario tool.
Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal Biotech that is off to a strong sales start.
TUESDAY, April 29, 2025 -- The U.S. Food and Drug Administration has approved Zevaskyn (prademagene zamikeracel) for patients with the rare, genetic skin disorder recessive dystrophic epidermolysis bullosa.Zevaskyn is the first and only autologous.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Scientists found that the fringe-lipped bat, known to eavesdrop on frog and toad mating calls to find its prey, learns to distinguish between palatable and unpalatable frogs and toads through experience. The findings provide the first evidence that eavesdropping predators fine-tune their hunting cues over the course of their development.
Trium Capital is the latest firm to push a biotech “zombie” to shut down, claiming in a regulatory filing there is more upside to a liquidation than Acelyrin’s planned merger.
TUESDAY, April 29, 2025 -- Telemedicine isnt only more convenient for patients, but could be helping save the planet, a new study says.Telemedicine use in 2023 reduced monthly carbon dioxide emissions by the equivalent of more than 130,000 e.
Deals with Hims & Hers, LifeMD and Ro following a court's dismissal of a lawsuit challenging the FDA's determination that Wegovy is no longer in shortage.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
TUESDAY, April 29, 2025 The U.S. Department of Health and Human Services (HHS) said it will not create a new autism registry, reversing an earlier announcement from the National Institutes of Health (NIH)."We are not creating an autism registry. T.
Clinical research is evolving as technology advancements enable more sophisticated drug development methods, dramatically increasing the speed, volume, and complexity of clinical trial data generation. Continuous data monitoring is now essential as sponsors must track ever-larger datasets to safeguard patient safety, data quality, and regulatory compliance.
TUESDAY, April 29, 2025 If you spend hours a day glued to your phone or seated at a desk, you're setting yourself up for serious neck pain, a recent study warns.Researchers in China looked at data from 25 studies involving more than 43,000 people.
ELRIG Announces USA Forum on Neuroimmunology in Drug Discovery ELRIGs USA Forum will take place in Boston, MA, USA, on 24 June 2025 Event will focus on Neuroimmunology in Drug Discovery Cambridge, UK, 29th April 2025: The European Laboratory Research & Innovation Group (ELRIG), a not-for-profit, volunteer-led organisation for the drug discovery community, today announced its first USA Forum.
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
By Naim Alkhouri, MD,FAASLD, DABOM. | How a commonly silent disease is driving urgency and novelty in the liver disease treatment paradigm and what can we hope for.
This content is password protected. To view it please enter your password below: Password: The post Protected: FUEL Leverages Halo to Support Energy Innovation Across Louisiana appeared first on Translation | Halo Blog.
The only eClinical platform to offer native web, mobile (iOS/Android), and Mac applications, redefining the standard for modern research software. The post Crucial Data Solutions Sets Another Industry Benchmark: TrialKit Now Available as a Native macOS App appeared first on Crucial Data Solutions.
TUESDAY, April 29, 2025 -- A significant number of long-term care patients consider their state a fate worse than death, as they become completely powerless and vulnerable due to their severe disabilities, a new study says.About 20% of people newly.
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Imagine a crocodile built like a greyhound -- that's a sebecid. Standing tall, with some species reaching 20 feet in length, they dominated South American landscapes after the extinction of dinosaurs until about 11 million years ago. Or at least, that's what paleontologists thought. A new study shows the Caribbean Islands were a refuge for the last sebecid populations at least 5 million years after they went extinct everywhere else.
TUESDAY, April 29, 2025 -- Chemicals commonly used in plastics appear to increase peoples risk of heart disease, a new study says.Daily exposure to just one type of phthalate could be linked to more than 365,000 deaths worldwide from heart disease.
Scientists believe they have found a way to improve warning systems for vulnerable communities threatened by humid heatwaves, which are on the rise due to climate change and can be damaging and even fatal to human health. The study analysed how patterns of recent rainfall can interact with dry or moist land conditions to influence the risk of extreme humid heat in the global tropics and subtropics.
Addgenes viral vector services allow scientists to conduct experiments faster, skipping the preparation steps of production, purification, and titering. Our newest viral vector service, AAV Packaged on Request has seen a fantastic response from the research community. Customers have taken advantage of the customizability, choosing the cargo, serotype, and prep size they need for their experiments and weve been able to ship them out in record time.
On the last day of February every year is Rare Disease Day , a dedicated day to celebrate the rare disease community, including patients, families, caregivers, clinicians, researchers, regulators, and more. The day inspires multiple events, such as fundraisers and scientific symposia, to bring together all the critical stakeholders who tirelessly work to make life better for those affected by rare diseases.
"Patent Infringement Alert: Are You Sitting on a Goldmine? Did you know that over 40% of pharmaceutical patents in the US are considered "weak" due to flawed patent applications or inadequate patent prosecution? At DrugPatentWatch, we've identified a staggering number of opportunities for generic manufacturers to invalidate these weak patents and bring affordable medications to market.
Strapi is the leading open-source headless CMS. It’s 100% JavaScript/ TypeScript , fully customizable, and developer-first. Its flexibility and scalability make it an ideal choice for businesses and organizations seeking to create unique digital experiences. Self-hosted or Cloud : We can host and scale Strapi (open-source headless CMS) projects the way you want.
"Market Access: The Hidden Hurdle in Generic Drug Commercialization As a seasoned pharmaceutical professional, I've seen it time and time again: a generic drug finally receives FDA approval, only to stall in the market due to a seemingly insurmountable obstacle - market access. But what exactly is market access, and why does it hold such sway over the commercialization of generic drugs?
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content